Zurich Cantonal Bank’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $68.7M | Buy |
88,871
+7,629
| +9% | +$5.84M | 0.15% | 122 |
|
|
2025
Q4 | $62.7M | Sell |
81,242
-17,601
| -18% | -$12M | 0.14% | 134 |
|
|
2025
Q3 | $55.6M | Sell |
98,843
-6,379
| -6% | -$3.61M | 0.13% | 133 |
|
|
2025
Q2 | $55.2M | Buy |
105,222
+7,854
| +8% | +$4.38M | 0.14% | 129 |
|
|
2025
Q1 | $61.8M | Sell |
97,368
-42,590
| -30% | -$29.3M | 0.18% | 101 |
|
|
2024
Q4 | $99.7M | Buy |
139,958
+209
| +0.1% | +$175K | 0.28% | 59 |
|
|
2024
Q3 | $147M | Sell |
139,749
-5,116
| -4% | -$5.69M | 0.44% | 35 |
|
|
2024
Q2 | $152M | Buy |
144,865
+67,235
| +87% | +$65.2M | 0.5% | 29 |
|
|
2024
Q1 | $74.7M | Buy |
77,630
+11,670
| +18% | +$11.1M | 0.26% | 69 |
|
|
2023
Q4 | $57.9M | Buy |
65,960
+552
| +0.8% | +$455K | 0.22% | 86 |
|
|
2023
Q3 | $53.8M | Buy |
65,408
+2,427
| +4% | +$1.91M | 0.24% | 79 |
|
|
2023
Q2 | $45.3M | Buy |
62,981
+2,991
| +5% | +$2.31M | 0.2% | 100 |
|
|
2023
Q1 | $49.3M | Buy |
59,990
+18,775
| +46% | +$14.2M | 0.24% | 84 |
|
|
2022
Q4 | $29.7M | Buy |
41,215
+7,222
| +21% | +$5.33M | 0.16% | 132 |
|
|
2022
Q3 | $23.4M | Buy |
33,993
+544
| +2% | +$342K | 0.14% | 141 |
|
|
2022
Q2 | $19.8M | Sell |
33,449
-7,964
| -19% | -$5.18M | 0.12% | 164 |
|
|
2022
Q1 | $28.9M | Buy |
41,413
+7,063
| +21% | +$4.47M | 0.14% | 133 |
|
|
2021
Q4 | $21.7M | Sell |
34,350
-16,003
| -32% | -$9.84M | 0.11% | 176 |
|
|
2021
Q3 | $30.5M | Sell |
50,353
-10,234
| -17% | -$6.35M | 0.16% | 116 |
|
|
2021
Q2 | $33.8M | Buy |
60,587
+8,133
| +16% | +$4.12M | 0.19% | 104 |
|
|
2021
Q1 | $24.8M | Buy |
52,454
+6,150
| +13% | +$2.99M | 0.15% | 135 |
|
|
2020
Q4 | $22.4M | Buy |
46,304
+8,651
| +23% | +$4.67M | 0.14% | 146 |
|
|
2020
Q3 | $21.1M | Buy |
37,653
+4,825
| +15% | +$2.93M | 0.15% | 125 |
|
|
2020
Q2 | $20.5M | Sell |
32,828
-5,292
| -14% | -$3M | 0.18% | 109 |
|
|
2020
Q1 | $18.6M | Buy |
38,120
+17,992
| +89% | +$7.42M | 0.17% | 118 |
|
|
2019
Q4 | $7.56M | Buy |
20,128
+577
| +3% | +$194K | 0.06% | 347 |
|
|
2019
Q3 | $5.42M | Buy |
19,551
+254
| +1% | +$75.2K | 0.05% | 394 |
|
|
2019
Q2 | $6.04M | Sell |
19,297
-1,758
| -8% | -$585K | 0.05% | 379 |
|
|
2019
Q1 | $8.65M | Buy |
21,055
+2,698
| +15% | +$1.11M | 0.08% | 286 |
|
|
2018
Q4 | $6.86M | Buy |
18,357
+3,349
| +22% | +$1.23M | 0.07% | 304 |
|
|
2018
Q3 | $6.06M | Sell |
15,008
-459
| -3% | -$175K | 0.05% | 378 |
|
|
2018
Q2 | $5.34M | Buy |
15,467
+630
| +4% | +$197K | 0.05% | 408 |
|
|
2018
Q1 | $5.11M | Hold |
14,837
| – | – | 0.05% | 411 |
|
|
2017
Q4 | $5.58M | Sell |
14,837
-3,117
| -17% | -$1.26M | 0.05% | 385 |
|
|
2017
Q3 | $8.03M | Buy |
17,954
+1,596
| +10% | +$759K | 0.07% | 314 |
|
|
2017
Q2 | $8.03M | Sell |
16,358
-1,298
| -7% | -$568K | 0.08% | 281 |
|
|
2017
Q1 | $6.84M | Sell |
17,656
-1,666
| -9% | -$618K | 0.07% | 317 |
|
|
2016
Q4 | $7.09M | Buy |
19,322
+2,821
| +17% | +$1.07M | 0.07% | 295 |
|
|
2016
Q3 | $6.63M | Buy |
16,501
+8,896
| +117% | +$3.57M | 0.07% | 319 |
|
|
2016
Q2 | $2.66M | Buy |
7,605
+500
| +7% | +$193K | 0.03% | 465 |
|
|
2016
Q1 | $2.56M | Buy |
7,105
+241
| +4% | +$99.3K | 0.03% | 478 |
|
|
2015
Q4 | $3.73M | Sell |
6,864
-1,154
| -14% | -$625K | 0.05% | 383 |
|
|
2015
Q3 | $3.73M | Buy |
8,018
+568
| +8% | +$305K | 0.05% | 354 |
|
|
2015
Q2 | $3.8M | Buy |
7,450
+2,330
| +46% | +$1.14M | 0.05% | 355 |
|
|
2015
Q1 | $2.31M | Buy |
5,120
+228
| +5% | +$96.6K | 0.03% | 476 |
|
|
2014
Q4 | $2.01M | Sell |
4,892
-438
| -8% | -$172K | 0.06% | 379 |
|
|
2014
Q3 | $1.92M | Sell |
5,330
-35,101
| -87% | -$11.8M | 0.06% | 363 |
|
|
2014
Q2 | $11.4M | Buy |
40,431
+7,731
| +24% | +$2.29M | 0.34% | 58 |
|
|
2014
Q1 | $9.82M | Sell |
32,700
-2,376
| -7% | -$732K | 0.3% | 66 |
|
|
2013
Q4 | $9.65M | Sell |
35,076
-1,170
| -3% | -$337K | 0.32% | 68 |
|
|
2013
Q3 | $11.3M | Sell |
36,246
-25,413
| -41% | -$6.68M | 0.39% | 50 |
|
|
2013
Q2 | $13.9M | Buy |
+61,659
| New | +$14.4M | 0.48% | 37 |
|
Other funds holding REGN
VCM
N
Zurich Cantonal Bank's REGN Position: Q1 2026 in Review
Zurich Cantonal Bank increased its Regeneron Pharmaceuticals (REGN) stake by 9.4% in Q1 2026, buying an estimated $5.84M and bringing the position to 88,871 shares worth $68.7M. The position accounts for 0.15% of the portfolio, ranked #122.
Zurich Cantonal Bank first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $152M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Zurich Cantonal Bank held 88,871 shares of Regeneron Pharmaceuticals worth $68.7M as of Q1 2026.
- Zurich Cantonal Bank bought 7,629 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $5.84M.
- Regeneron Pharmaceuticals made up 0.15% of Zurich Cantonal Bank's portfolio in Q1 2026, its #122 holding.
- Zurich Cantonal Bank first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Zurich Cantonal Bank's Regeneron Pharmaceuticals position peaked at $152M in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Zurich Cantonal Bank's 13F filing for Q1 2026, filed 15 May 2026.